Fig. 1.
Patient experience a with prior anti-TNF agent and with golimumab vs. prior anti-TNF agent (adalimumab at week -2/etanercept at week -1) at b week 8 and c week 44. TNF Tumor necrosis factor
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.